Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice

D J Daly, Paul S Myles, Julian Anderson Smith, J L Knights, Ornella Clavisi, David Bain, R Glew, Neville Gibbs, A F Merry

Research output: Contribution to journalArticleResearchpeer-review

Abstract

We surveyed contemporary Australasian cardiac surgical and anaesthetic practice, focusing on antiplatelet and antifibrinolytic therapies and blood transfusion practices. The cohort included 499 sequential adult cardiac surgical patients in 12 Australasian teaching hospitals. A total of 282 (57 ) patients received red cell or component transfusion. The median (IQR) red cell transfusion threshold haemogloblin levels were 66 (61-73) g/l intraoperatively and 79 (74-85) g/l postoperatively. Many (40 ) patients had aspirin within five days of surgery but this was not associated with blood loss or transfusion; 15 had clopidogrel within seven days of surgery. In all, 30 patients (6 ) required surgical re-exploration for bleeding. Factors associated with transfusion and excessive bleeding include pre-existing renal impairment, preoperative clopidogrel therapy, and complex or emergency surgery. Despite frequent (67 ) use of antifibrinolytic therapy, there was a marked variability in red cell transfusion rates between centres (range 17 to 79 , P <0.001). This suggests opportunities for improvement in implementation of guidelines and effective blood-sparing interventions. Many patients presenting for surgery receive antiplatelet and/or antifibrinolytic therapy, yet the subsequent benefits and risks remain unclear.
Original languageEnglish
Pages (from-to)760 - 768
Number of pages9
JournalAnaesthesia and intensive care
Volume35
Issue number5
Publication statusPublished - 2007

Cite this

Daly, D J ; Myles, Paul S ; Smith, Julian Anderson ; Knights, J L ; Clavisi, Ornella ; Bain, David ; Glew, R ; Gibbs, Neville ; Merry, A F. / Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice. In: Anaesthesia and intensive care. 2007 ; Vol. 35, No. 5. pp. 760 - 768.
@article{e61c2a68533140a5ae947c9db6000235,
title = "Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice",
abstract = "We surveyed contemporary Australasian cardiac surgical and anaesthetic practice, focusing on antiplatelet and antifibrinolytic therapies and blood transfusion practices. The cohort included 499 sequential adult cardiac surgical patients in 12 Australasian teaching hospitals. A total of 282 (57 ) patients received red cell or component transfusion. The median (IQR) red cell transfusion threshold haemogloblin levels were 66 (61-73) g/l intraoperatively and 79 (74-85) g/l postoperatively. Many (40 ) patients had aspirin within five days of surgery but this was not associated with blood loss or transfusion; 15 had clopidogrel within seven days of surgery. In all, 30 patients (6 ) required surgical re-exploration for bleeding. Factors associated with transfusion and excessive bleeding include pre-existing renal impairment, preoperative clopidogrel therapy, and complex or emergency surgery. Despite frequent (67 ) use of antifibrinolytic therapy, there was a marked variability in red cell transfusion rates between centres (range 17 to 79 , P <0.001). This suggests opportunities for improvement in implementation of guidelines and effective blood-sparing interventions. Many patients presenting for surgery receive antiplatelet and/or antifibrinolytic therapy, yet the subsequent benefits and risks remain unclear.",
author = "Daly, {D J} and Myles, {Paul S} and Smith, {Julian Anderson} and Knights, {J L} and Ornella Clavisi and David Bain and R Glew and Neville Gibbs and Merry, {A F}",
year = "2007",
language = "English",
volume = "35",
pages = "760 -- 768",
journal = "Anaesthesia and intensive care",
issn = "0310-057X",
publisher = "Australian Society of Anaesthetists",
number = "5",

}

Daly, DJ, Myles, PS, Smith, JA, Knights, JL, Clavisi, O, Bain, D, Glew, R, Gibbs, N & Merry, AF 2007, 'Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice' Anaesthesia and intensive care, vol. 35, no. 5, pp. 760 - 768.

Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice. / Daly, D J; Myles, Paul S; Smith, Julian Anderson; Knights, J L; Clavisi, Ornella; Bain, David; Glew, R; Gibbs, Neville; Merry, A F.

In: Anaesthesia and intensive care, Vol. 35, No. 5, 2007, p. 760 - 768.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice

AU - Daly, D J

AU - Myles, Paul S

AU - Smith, Julian Anderson

AU - Knights, J L

AU - Clavisi, Ornella

AU - Bain, David

AU - Glew, R

AU - Gibbs, Neville

AU - Merry, A F

PY - 2007

Y1 - 2007

N2 - We surveyed contemporary Australasian cardiac surgical and anaesthetic practice, focusing on antiplatelet and antifibrinolytic therapies and blood transfusion practices. The cohort included 499 sequential adult cardiac surgical patients in 12 Australasian teaching hospitals. A total of 282 (57 ) patients received red cell or component transfusion. The median (IQR) red cell transfusion threshold haemogloblin levels were 66 (61-73) g/l intraoperatively and 79 (74-85) g/l postoperatively. Many (40 ) patients had aspirin within five days of surgery but this was not associated with blood loss or transfusion; 15 had clopidogrel within seven days of surgery. In all, 30 patients (6 ) required surgical re-exploration for bleeding. Factors associated with transfusion and excessive bleeding include pre-existing renal impairment, preoperative clopidogrel therapy, and complex or emergency surgery. Despite frequent (67 ) use of antifibrinolytic therapy, there was a marked variability in red cell transfusion rates between centres (range 17 to 79 , P <0.001). This suggests opportunities for improvement in implementation of guidelines and effective blood-sparing interventions. Many patients presenting for surgery receive antiplatelet and/or antifibrinolytic therapy, yet the subsequent benefits and risks remain unclear.

AB - We surveyed contemporary Australasian cardiac surgical and anaesthetic practice, focusing on antiplatelet and antifibrinolytic therapies and blood transfusion practices. The cohort included 499 sequential adult cardiac surgical patients in 12 Australasian teaching hospitals. A total of 282 (57 ) patients received red cell or component transfusion. The median (IQR) red cell transfusion threshold haemogloblin levels were 66 (61-73) g/l intraoperatively and 79 (74-85) g/l postoperatively. Many (40 ) patients had aspirin within five days of surgery but this was not associated with blood loss or transfusion; 15 had clopidogrel within seven days of surgery. In all, 30 patients (6 ) required surgical re-exploration for bleeding. Factors associated with transfusion and excessive bleeding include pre-existing renal impairment, preoperative clopidogrel therapy, and complex or emergency surgery. Despite frequent (67 ) use of antifibrinolytic therapy, there was a marked variability in red cell transfusion rates between centres (range 17 to 79 , P <0.001). This suggests opportunities for improvement in implementation of guidelines and effective blood-sparing interventions. Many patients presenting for surgery receive antiplatelet and/or antifibrinolytic therapy, yet the subsequent benefits and risks remain unclear.

UR - http://www.aaic.net.au/

M3 - Article

VL - 35

SP - 760

EP - 768

JO - Anaesthesia and intensive care

JF - Anaesthesia and intensive care

SN - 0310-057X

IS - 5

ER -